Patents-Review.com
ClassID:

96455 ⎘

C07J1/0029 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane; Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified Ethers

Recent Application in this class:
#1
20260151489
2026-06-04

LYMPH DIRECTING PRODRUGS

 #2
20260102373
2026-04-16

LYMPH DIRECTING PRODRUGS

 #3
20260034146
2026-02-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #4
20260014170
2026-01-15

PRODRUGS FOR DELIVERY OF TESTOSTERONE TO THE CENTRAL NERVOUS SYSTEM

 #5
20260000769
2026-01-01

LYMPH DIRECTING PRODRUGS

 #6
20250352510
2025-11-20

LYMPH DIRECTING PRODRUGS

 #7
20250325671
2025-10-23

LYMPH DIRECTING PRODRUGS

 #8
20250312461
2025-10-09

LYMPH DIRECTING PRODRUGS

 #9
20250257092
2025-08-14

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #10
20250213522
2025-07-03

LYMPH DIRECTING PRODRUGS

 #11
20250092084
2025-03-20

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #12
20240050573
2024-02-15

LYMPH DIRECTING PRODRUGS

 #13
20230192756
2023-06-22

Neuroactive steroids, compositions, and uses thereof

 #14
20230190770
2023-06-22

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #15
20230116347
2023-04-13

C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #16
20230021308
2023-01-19

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #17
20220211664
2022-07-07

LYMPH DIRECTING PRODRUGS

 #18
20220002340
2022-01-06

C7, C12, and C16 substituted neuroactive steroids and their methods of use

 #19
20210308149
2021-10-07

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #20
20210147470
2021-05-20

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #21
20200113916
2020-04-16

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #22
20190248831
2019-08-15

C17, C20, and C21 substituted neuroactive steroids and their methods of use

 #23
20190233465
2019-08-01

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #24
20190105299
2019-04-11

LYMPH DIRECTING PRODRUGS

 #25
20180362573
2018-12-20

Neuroactive steroids, compositions, and uses thereof

 #26
20180243426
2018-08-30

Compounds and methods for trans-membrane delivery of molecules

 #27
20180243425
2018-08-30

Lymph directing prodrugs

 #28
20170326103
2017-11-16

Lymph directing prodrugs

 #29
20170190732
2017-07-06

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #30
20170152282
2017-06-01

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #31
20150315230
2015-11-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #32
20150175651
2015-06-25

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #33
20140235600
2014-08-21

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #34
20050143366
2005-06-30

Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders